List of works - Arnulf Ferlitsch

Betablockers do not increase efficacy of band ligation in primary prophylaxis but they improve survival in secondary prophylaxis of variceal bleeding.

scientific article published in February 2018

Carvedilol for reducing portal pressure in primary prophylaxis of variceal bleeding: a dose-response study

scientific article published on 28 February 2018

Combination of phosphodiesterase-5-inhibitors and beta blockers improves experimental portal hypertension and erectile dysfunction

scientific article published on 06 July 2020

Controlled attenuation parameter does not predict hepatic decompensation in patients with advanced chronic liver disease

scientific article published on 22 September 2018

Editorial: getting bullish about portal hypertension-chronic treatment with oral taurine? Author's reply

scientific article published in February 2018

Editorial: optimal dose of carvedilol in portal hypertension…nearly there. Authors' reply

scientific article published on 01 May 2018

Editorial: surviving your genes-the role of PNPLA3 variation in end-stage liver disease. Authors' reply

scientific article published on 01 October 2018

Editorial: von Willebrand factor and CRP levels may predict survival in liver cirrhosis-Authors' reply

scientific article published on 01 June 2018

Erectile dysfunction in cirrhosis is impacted by liver dysfunction, portal hypertension, diabetes and arterial hypertension.

scientific article published on 24 January 2018

Evaluation of a new balloon occlusion catheter specifically designed for measurement of hepatic venous pressure gradient.

scientific article published on 30 January 2015

Impact of HSD17B13 rs72613567 genotype on hepatic decompensation and mortality in patients with portal hypertension

scientific article published on 03 December 2019

Impact of acute kidney injury on prognosis of patients with liver cirrhosis and ascites: A retrospective cohort study.

scientific article published on 13 May 2015

Impact of patatin-like phospholipase domain containing 3 rs738409 G/G genotype on hepatic decompensation and mortality in patients with portal hypertension.

scientific article published on 29 June 2018

Low vitamin D levels are associated with impaired virologic response to PEGIFN + RBV therapy in HIV-hepatitis C virus coinfected patients

scientific article published on January 2013

New reliability criteria for transient elastography increase the number of accurate measurements for screening of cirrhosis and portal hypertension.

scientific article published on 9 July 2014

Nonselective β blockers increase risk for hepatorenal syndrome and death in patients with cirrhosis and spontaneous bacterial peritonitis

scientific article published on 12 March 2014

Performance of 2-D shear wave elastography in liver fibrosis assessment compared with serologic tests and transient elastography in clinical routine

scientific article published on 23 May 2015

Plasma renin concentration represents an independent risk factor for mortality and is associated with liver dysfunction in patients with cirrhosis

scientific article

Proton pump inhibitor intake neither predisposes to spontaneous bacterial peritonitis or other infections nor increases mortality in patients with cirrhosis and ascites.

scientific article

Randomised clinical study: the effects of oral taurine 6g/day vs placebo on portal hypertension.

scientific article published on 3 November 2017

Revisiting liver disease progression in HIV/HCV-coinfected patients: the influence of vitamin D, insulin resistance, immune status, IL28B and PNPLA3.

scientific article published on 26 June 2014

Risk factors for development of spontaneous bacterial peritonitis and subsequent mortality in cirrhotic patients with ascites

scientific article published on 2 February 2015

Sustained virologic response to interferon-free therapies ameliorates HCV-induced portal hypertension

scientific article

The trigger matters - outcome of hepatorenal syndrome vs. specifically triggered acute kidney injury in cirrhotic patients with ascites.

scientific article published on 12 May 2016

The value of different CT-based methods for diagnosing low muscle mass and predicting mortality in patients with cirrhosis

scientific article published on 11 September 2019

Von Willebrand factor indicates bacterial translocation, inflammation, and procoagulant imbalance and predicts complications independently of portal hypertension severity.

scientific article

List of works by Arnulf Ferlitsch

Betablockers do not increase efficacy of band ligation in primary prophylaxis but they improve survival in secondary prophylaxis of variceal bleeding.

Carvedilol for reducing portal pressure in primary prophylaxis of variceal bleeding: a dose-response study

Combination of phosphodiesterase-5-inhibitors and beta blockers improves experimental portal hypertension and erectile dysfunction

Controlled attenuation parameter does not predict hepatic decompensation in patients with advanced chronic liver disease

Editorial: getting bullish about portal hypertension-chronic treatment with oral taurine? Author's reply

Editorial: optimal dose of carvedilol in portal hypertension…nearly there. Authors' reply

Editorial: surviving your genes-the role of PNPLA3 variation in end-stage liver disease. Authors' reply

Editorial: von Willebrand factor and CRP levels may predict survival in liver cirrhosis-Authors' reply

Erectile dysfunction in cirrhosis is impacted by liver dysfunction, portal hypertension, diabetes and arterial hypertension.

Evaluation of a new balloon occlusion catheter specifically designed for measurement of hepatic venous pressure gradient.

Impact of HSD17B13 rs72613567 genotype on hepatic decompensation and mortality in patients with portal hypertension

Impact of acute kidney injury on prognosis of patients with liver cirrhosis and ascites: A retrospective cohort study.

Impact of patatin-like phospholipase domain containing 3 rs738409 G/G genotype on hepatic decompensation and mortality in patients with portal hypertension.

Low vitamin D levels are associated with impaired virologic response to PEGIFN + RBV therapy in HIV-hepatitis C virus coinfected patients

New reliability criteria for transient elastography increase the number of accurate measurements for screening of cirrhosis and portal hypertension.

Nonselective β blockers increase risk for hepatorenal syndrome and death in patients with cirrhosis and spontaneous bacterial peritonitis

Performance of 2-D shear wave elastography in liver fibrosis assessment compared with serologic tests and transient elastography in clinical routine

Plasma renin concentration represents an independent risk factor for mortality and is associated with liver dysfunction in patients with cirrhosis

Proton pump inhibitor intake neither predisposes to spontaneous bacterial peritonitis or other infections nor increases mortality in patients with cirrhosis and ascites.

Randomised clinical study: the effects of oral taurine 6g/day vs placebo on portal hypertension.

Revisiting liver disease progression in HIV/HCV-coinfected patients: the influence of vitamin D, insulin resistance, immune status, IL28B and PNPLA3.

Risk factors for development of spontaneous bacterial peritonitis and subsequent mortality in cirrhotic patients with ascites

Sustained virologic response to interferon-free therapies ameliorates HCV-induced portal hypertension

The trigger matters - outcome of hepatorenal syndrome vs. specifically triggered acute kidney injury in cirrhotic patients with ascites.

The value of different CT-based methods for diagnosing low muscle mass and predicting mortality in patients with cirrhosis

Von Willebrand factor indicates bacterial translocation, inflammation, and procoagulant imbalance and predicts complications independently of portal hypertension severity.